Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54.
Chu CY, Rana TM. · 2006
Read Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. by Chu CY, Rana TM. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1475773.txt.
Introduction
Tiny RNAs called microRNAs can mute a gene without cutting its message. Chu and Rana pinpointed a helper protein for that muting in 2006. The protein, RCK/p54, unwinds RNA and partners with the silencing machinery in human cells. It also helps form P-bodies, cell spots where messages are stored or broken down.
Removing RCK/p54 scattered those spots and freed genes from microRNA control. Yet cutting of messages by a sister process went on fine. Chu proposes that silencing complexes use RCK/p54 to block protein building. The microRNA itself picks which message gets blocked, by matching its tail end.
Catalog record
| CREATOR | Chu CY, Rana TM. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54 By Chia-ying Chu, Tariq M Rana, James Carrington Published in: PLoS Biology DOI: 10.1371/journal.pbio.0040210 ABSTRACT RNA interference is triggered by double-stranded RNA that is processed into small interfering RNAs (siRNAs) by Dicer enzyme. Endogenously, RNA interference triggers are created from small noncoding RNAs called microRNAs (miRNAs). RNA-induced silencing complexes (RISC) in human cells can be programmed by exogenously introduced siRNA or endogenously expressed miRNA. siRNA-programmed RISC (siRISC) silences expression by cleaving a perfectly complementary target mRNA, whereas miRNA-induced silencing complexes (miRISC) inhibits translation by binding imperfectly matched sequences in the 3′ UTR of target mRNA. Both RISCs contain Argonaute2 (Ago2), which catalyzes target mRNA cleavage by siRISC and localizes to cytoplasmic mRNA processing bodies (P-bodies). Here, we show that RCK/p54, a DEAD box helicase, interacts with argonaute proteins, Ago1 and Ago2, in affinity-purified active siRISC or miRISC from human cells; directly interacts with Ago1 and Ago2 in vivo, facilitates formation of P-bodies, and is a general repressor of translation. Disrupting P-bodies by depleting Lsm1 did not affect RCK/p54 interactions with argonaute proteins and its function in miRNA-mediated translation repression. Depletion of RCK/p54 disrupted P-bodies and dispersed Ago2 throughout the cytoplasm but did not significantly affect siRNA-mediated RNA functions of RISC. Depleting RCK/p54 released general, miRNA-induced, and let-7-mediated translational repression. Therefore, we propose that translation repression is mediated by miRISC via RCK/p54 and its specificity is dictated by the miRNA sequence binding multiple copies of miRISC to complementary 3′ UTR sites in the target mRNA. These studies also suggest that translation suppression by miRISC does not require P-body structures, and location of miRISC to P-bodies is the consequence of translation repression. INTRODUCTION Small non-coding RNAs play important roles in the posttranscriptional regulation of genes that code for diverse biological functions, e.g., in most metazoan organisms from nematodes to mammals [ 1– 3]. Two classes of such small (∼ 21 nucleotide [nt]) RNAs that have been extensively studied in gene silencing are short interfering RNAs (siRNAs) and microRNAs (miRNAs) (reviewed in [ 4]). Currently, the best known mechanism of gene silencing is RNA interference (RNAi), an evolutionarily conserved process whereby double-stranded RNA induces the sequence-specific degradation of homologous mRNA [ 5]. Long double-stranded RNA and precursors of miRNAs are processed by Dicer enzyme, and siRNAs are assembled into an RNA-induced silencing complex called RISC. The RNAi machinery can also be programmed in cells by introducing duplexes of siRNAs that are assembled into RNA-induced silencing complexes (siRISC) containing Dicer, argonautes, and other proteins [ 6]. Although RNAi has commonly been associated with siRNAs, this process is largely mediated in plants by miRNAs [ 7, 8], and examples of miRNA-mediated RNAi have been found in mammals and viruses (reviewed in [ 6]). Growing evidence indicates that miRNAs are important in human disease, including cancers [ 9– 12]. For example, relatively low levels of let-7 miRNA up-regulate RAS protein in lung cancer cells, demonstrating a possible role of miRNA in tumorigenesis [ 13]. Both classes of small RNAs are assembled into silencing complexes that contain Dicer, argonautes, and other proteins [ 4], but they silence gene expression by two different pathways. Upon recognizing complementary mRNA, activated RISC forms an effector complex with the target mRNA [ 6]. Antisense siRNA in activated RISC serves as a guide for Argonaute2 (Ago2) [ 14– 16] to catalyze the cleavage of target mRNA at a site ∼ 10 nt from the 5′ end of the siRNA [ 17]. Following cleavage, the target mRNA is degraded. Activated RISC, as a multi-turnover enzyme [ 18], is recycled to cleave additional mRNA targets. In the case of miRNAs, they are assembled into miRNA-induced silencing complexes (miRISC) that contain Dicer, argonaute proteins, transactivation-responsive RNA-binding protein [ 19– 22], and other cellular factors [ 4]. This assembly into miRISC has been implicated in miRNA functions [ 19– 24]. Whether siRNA-mediated RNAi or miRNA-mediated inhibition of translation is triggered depends largely on the degree of complementarity between the siRNA or miRNA and its mRNA target (reviewed in [ 2, 25]). While both miRNAs and siRNAs must harbor sequences that recognize the target mRNA, miRNAs are generally not fully complementary to the mRNA target. In contrast, siRNA sequences must be completely complementary to the mRNA target cleavage site to efficiently induce cleavage through the RNAi pathway. Interestingly, miRNAs can behave like siRNAs and induce mRNA cleavage when the miRNA sequence is completely complementary to a target mRNA [ 18, 26, 27]. In human cells, the mechanism by which the endogenous miRNA and siRNA pathways are distinguished is not clearly understood. It is also unclear how miRNAs repress the translation of target mRNAs. New insights into miRNA function have recently been provided by localization of the RISC components, Ago1 and Ago2, in mRNA-processing bodies (P-bodies) [ 28– 31], which are cytoplasmic foci containing translationally repressed mRNP complexes. During cellular translational control, an mRNP complex is formed containing the translationally repressed mRNA and associated repressor proteins and lacking translation initiation factors [ 32]. These translationally repressed mRNPs accumulate in P-bodies and contain proteins that mediate the translation [ 33– 35], RNAi [ 28– 31, 36], translation suppression [ 37], and decay [ 32, 38] of cellular mRNA. P-bodies, also referred to as GW or Dcp bodies, contain GW182 proteins that have recently been reported to play a role in RNAi [ 39– 41]. Other proteins found in cytoplasmic P-bodies and implicated in mRNA processing are RCK/p54, Lsm1, Dcp1:2, and eIF4E [ 32, 33, 38]. Given that target mRNA and RISC components have been co-localized in P-bodies [ 29, 31], it is possible that P-bodies are the bona fide site for RISC-induced target cleavage or repression of translation. However, the mechanism by which target mRNA and miRISC are directed to P-bodies and how translation is repressed by miRISC is still unknown. One P-body protein, RCK/p54, the human homolog of yeast Dhh1p, is a member of the ATP-dependent DEAD box helicase family and was originally identified as a proto-oncogene [ 42]. In human cells, RCK/p54 interacts in P-bodies with the translation initiation factor, eIF4E [ 33]. The Xenopus homolog of RCK/p54, Xp54, which interacts with eIF4E and forms RNA-dependent oligomers, represses the translation of mRNA in oocytes and eggs [ 43]. In yeast, Dhh1p interacts with the decapping and deadenylase complex and functions in translational repression [ 44]. Dhh1p has also recently been shown to stimulate translational repression by inhibiting production of the pre-initiation complex [ 45]. Here, we show that RCK/p54 interacts with argonaute proteins, Ago1 and Ago2, in affinity-purified active RISC assemblies from human cells programmed with siRNA or endogenous miRNA; directly interacts with Ago1 and Ago2 in vivo, facilitates formation of cytoplasmic P-bodies, and acts as a general repressor of translation. Depletion of RCK/p54 disrupted P-bodies and dispersed Ago2 throughout the cytoplasm. We further show that depletion of RCK/p54 did not significantly affect the RNAi function of RISC, but released general, miRNA-induced and let-7-mediated translational repression. Taken together, our results suggest that RCK/p54 is the effector molecule in miRISC that represses translation and that the specificity of this repression is dictated by the sequence of miRNA binding to complementary sites in the 3′ UTR of the